SNWV NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

SANUWAVE Health, Inc. Common Stock · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 6.17 USD
4.0% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -65.5% below the Trend Line and sits at 1.0% of its 52-week range. The latest completed week returned 4.0%, after a -42.0% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers. The latest news-sentiment score is 51/100. Near-term considerations: volume confirmation is below normal; earnings are due in 11d.

Setup score 14 out of 100
Latest Close 6.17 USD 31 Jul 2026
1W Return 4.0% latest completed week
4W Return -42.0% short-term follow-through
12W Return -60.4% quarterly tape
Trend Breadth 21.2% 11 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 4.0% Latest completed week; four-week move -42.0%. Indicator stack 12/25 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 39.62% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 51/100 44 relevant articles in the latest sentiment read. Event risk 11d Next report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -65.5% below the Trend Line and sits at 1.0% of its 52-week range. The latest completed week returned 4.0%, after a -42.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0112-week average 0.01

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.01Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -42.0% over four weeks, -60.4% over 12 weeks, and -83.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W4.0%
4W-42.0%
12W-60.4%
26W-77.1%
52W-83.0%
Active trend streak0 weeks
Active weeks in one year11
Trend breadth21.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.94Latest activity-pressure read.
Pressure change-103.0%Four-week change in activity pressure.
Leadership-77.94Latest relative-leadership reading.
RS change-16.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 02 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 91% Model confidence 86%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength86/100Blend of value, momentum, and quality. Underlying universe rank 15; rank 1 is best.
Value91/100Relative valuation strength. Underlying universe rank 10; rank 1 is best.
Quality95/100Profitability and accounting quality. Underlying universe rank 6; rank 1 is best.
Momentum7/100Medium-term price momentum. Underlying universe rank 94; rank 1 is best.
Growth80/100Revenue and earnings growth. Underlying universe rank 21; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
3.3x
Price divided by trailing earnings.
Price / sales
1.2x
Market value relative to trailing revenue.
EV / EBITDA
2.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
14.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
75.7%
Gross profit retained from each unit of revenue.
Operating margin
47.5%
Operating profit retained from revenue.
Free-cash-flow margin
21.2%
Free cash flow generated from revenue.
Return on invested capital
158.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
22.5%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
2402.4%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-1.1%
Net share repurchases relative to market value.
Shareholder yield
-1.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity5 / 11

5 acquisitions and 11 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment51/100

Weighted news tone is neutral across 44 relevant articles.

4 positive · 39 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings11dNext report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-86.8%Distance below the 52-week high.
13-week volatility17.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher7 of 2619 weeks finished lower.
Best week+23.5%Week of 3 Jul.
Worst week-45.3%Week of 17 Jul.
Latest week+4.0%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains2
Flat weeks0
Modest losses6
Sharp losses13
Recent vol17.8%13-week weekly-return volatility.
Base vol11.3%52-week weekly-return volatility.
Up/down split18/34Count of positive and negative weeks in the 52-week window.
Average skew7.6% / -8.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape16/100

Trend, activity pressure, participation, and risk combine to a 16/100 tape read.

 Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.01; No reversal markers Next-Week ExpectancyNegative 39.62%

Next-week expectancy is negative with a 39.62% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors71/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 77; Small Cap Core rank 34 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment51/100

Weighted news tone is neutral across 44 relevant articles.

Opaleye group (SNWV) discloses 3.60% SANUWAVE Health stake below 5% threshold Insiders5 / 11

5 acquisitions and 11 disposals in the latest 180-day insider tape.

 Earnings11d

Next report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20266.17 USD4.0%17.90 USD18.61 USD-0.94-77.94689.4KOff
24 Jul 20265.93 USD-7.2%18.66 USD18.62 USD-0.71-79.241.1MOff
17 Jul 20266.39 USD-45.3%19.48 USD18.62 USD-0.45-78.573.4MOff
10 Jul 202611.68 USD9.9%20.34 USD18.62 USD-0.42-63.45770.0KOff
3 Jul 202610.63 USD23.5%21.00 USD18.60 USD-0.46-66.81611.1KOff
26 Jun 20268.61 USD-6.5%21.74 USD18.57 USD-0.46-73.371.7MOff
19 Jun 20269.21 USD-38.2%22.58 USD18.57 USD-0.46-73.282.0MOff
12 Jun 202614.91 USD1.0%23.38 USD18.55 USD-0.55-56.51330.9KOff
5 Jun 202614.76 USD-10.4%23.98 USD18.51 USD-0.57-56.58355.6KOff
29 May 202616.47 USD-1.3%24.53 USD18.46 USD-0.70-54.32285.3KOff
22 May 202616.69 USD-0.9%24.94 USD18.39 USD-0.81-52.89360.1KOff
15 May 202616.85 USD8.2%25.42 USD18.33 USD-0.96-52.47895.7KOff
8 May 202615.57 USD-1.0%25.99 USD18.27 USD-1.09-56.86491.5KOff
1 May 202615.73 USD-15.9%26.54 USD18.21 USD-1.20-54.71703.8KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.